Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Supramolecular Modulation of Structural Polymorphism in Pathogenic α-Synuclein Fibrils Using Copper(II) Coordination

Journal Article · · Angewandte Chemie (International Edition)
 [1];  [2];  [1];  [2];  [3];  [4];  [2];  [1]
  1. Department of Chemistry, Korea University, Seoul 02841 Republic of Korea
  2. Department of Biomedical Sciences, Neuroscience Research Institute, Seoul National University College of Medicine, Seoul 03080 Republic of Korea
  3. Department of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles CA 90095 USA; Systems Biology Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330 Thailand
  4. Department of Chemistry and Biochemistry, University of California-Los Angeles, Los Angeles CA 90095 USA; Department of Biological Chemistry, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles CA 90095 USA; UCLA Molecular Biology Institute, UCLA/DOE Institute for Genomics and Proteomics, University of California-Los Angeles, Los Angeles CA 90095 USA

Not provided.

Research Organization:
Univ. of California, Los Angeles, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
FC02-02ER63421
OSTI ID:
1537468
Journal Information:
Angewandte Chemie (International Edition), Vol. 57, Issue 12; ISSN 1433-7851
Publisher:
Wiley
Country of Publication:
United States
Language:
English

References (36)

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies February 2017
 -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies May 1998
Animal models of α-synucleinopathy for Parkinson disease drug development July 2017
Solution conditions determine the relative importance of nucleation and growth processes in  -synuclein aggregation May 2014
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies July 2013
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death October 2011
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein March 2016
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration June 2015
Structural and functional characterization of two alpha-synuclein strains October 2013
Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies June 2017
Metabolism and functions of copper in brain May 2014
Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases October 2012
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity October 2016
Bioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease October 2012
Metalloproteomics and metal toxicology of α-synuclein January 2010
Localization of copper and copper transporters in the human brain January 2013
Dopaminergic Loss and Inclusion Body Formation in -Synuclein Mice: Implications for Neurodegenerative Disorders February 2000
Substantia nigra in Parkinson’s disease: a multimodal MRI comparison between early and advanced stages of the disease December 2013
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease January 2015
Structural characterization of copper(II) binding to  -synuclein: Insights into the bioinorganic chemistry of Parkinson's disease March 2005
Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity May 2010
Unique copper-induced oligomers mediate alpha-synuclein toxicity August 2009
Nanoscale Control of Amyloid Self-Assembly Using Protein Phase Transfer by Host-Guest Chemistry July 2017
Affinity of copper and zinc ions to proteins and peptides related to neurodegenerative conditions (Aβ, APP, α-synuclein, PrP) October 2012
Coordination Features and Affinity of the Cu 2+ Site in the α-Synuclein Protein of Parkinson’s Disease March 2011
Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases January 2012
A Revised Picture of the Cu(II)−α-Synuclein Complex: The Role of N-Terminal Acetylation April 2014
Probing Conformational Change of Intrinsically Disordered α-Synuclein to Helical Structures by Distinctive Regional Interactions with Lipid Membranes January 2014
Cu 2+ Binding Modes of Recombinant α-Synuclein − Insights from EPR Spectroscopy June 2008
Remote His50 Acts as a Coordination Switch in the High-Affinity N-Terminal Centered Copper(II) Site of α-Synuclein April 2015
Mapping Long-Range Interactions in α-Synuclein using Spin-Label NMR and Ensemble Molecular Dynamics Simulations January 2005
A practical guide to small angle X-ray scattering (SAXS) of flexible and intrinsically disordered proteins August 2015
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril August 2016
Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer’s disease October 2016
Molecular Insights into Human Serum Albumin as a Receptor of Amyloid-β in the Extracellular Region October 2017
Structure and assembly mechanisms of toxic human islet amyloid polypeptide oligomers associated with copper January 2016